Search Results - Oddbjørn Straume

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas

    Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas by Oddbjørn Straume, Lars A. Akslen

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression

    Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and E... by Oddbjørn Straume, Lars A. Akslen

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma

    Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma by Oddbjørn Straume, Lars A. Akslen

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Bevacizumab therapy for POEMS syndrome

    Bevacizumab therapy for POEMS syndrome by Oddbjørn Straume, Jann Bergheim, Peter Ernst

    Published 2006
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  5. 5
    Are 90% of deaths from cancer caused by metastases?

    Are 90% of deaths from cancer caused by metastases? by Hanna Dillekås, Michael S. Rogers, Oddbjørn Straume

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Tumor‐vascular interactions and tumor dormancy

    Tumor‐vascular interactions and tumor dormancy by George N. Naumov, Judah Folkman, Oddbjørn Straume, Lars A. Akslen

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma

    Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma by Rita G Ladstein, Ingeborg Bachmann, Oddbjørn Straume, Lars A. Akslen

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

    Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma by Rita G Ladstein, Ingeborg Bachmann, Oddbjørn Straume, Lars A. Akslen

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years

    Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years by Gry Haaland, Ragnhild Sørum Falk, Oddbjørn Straume, James B. Lorens

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase

    Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase by Oddbjørn Straume, Johanna Smeds, Rajiv Kumar, Kari Hemminki, Lars A. Akslen

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma

    Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma by Ingeborg Bachmann, Oddbjørn Straume, Hanne Puntervoll, May Britt Kalvenes, Lars A. Akslen

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases

    The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases by Hanna Dillekås, Romano Demicheli, Ilaria Ardoino, Svein Arthur Jensen, Elia Biganzoli, Oddbjørn Straume

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival

    BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival by Lars A. Akslen, Sabrina Angelini, Oddbjørn Straume, Ingeborg Bachmann, Anders Molven, Kari Hemminki, Rajiv Kumar

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare

    A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare by Rajiv Kumar, Johanna Smeds, Petra Berggren, Oddbjørn Straume, Barbro Lundh Rozell, Lars A. Akslen, Kari Hemminki

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension

    Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension by Cornelia Schuster, Hans Petter Eikesdal, Hanne Puntervoll, Jürgen Geisler, Stephanie Geisler, Daniel Heinrich, Anders Molven, Per Eystein Lønning, Lars A. Akslen, Oddbjørn Straume

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

    A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype by George N. Naumov, Elise R. Bender, David Zurakowski, Soo-Young Kang, David A. Sampson, Evelyn Flynn, Randolph S. Watnick, Oddbjørn Straume, Lars A. Akslen, Judah Folkman, Nava Almog

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance by George N. Naumov, Monique B. Nilsson, Tina Cascone, Alexandra Briggs, Oddbjørn Straume, Lars A. Akslen, Eugene Lifshits, Lauren A. Byers, Li Xu, Hua-Kang Wu, Pasi A. Jänne, Susumu Kobayashi, Balázs Halmos, Daniel G. Tenen, Xiaoou Tang, Jeffrey A. Engelman, Beow Y. Yeap, Judah Folkman, Bruce E. Johnson, John V. Heymach

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer

    Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer by Oddbjørn Straume, Takeshi Shimamura, Michael Lampa, Julián Carretero, Anne M. Øyan, Di Jia, Christa L. Borgman, Margaret Soucheray, Sean R. Downing, Sarah M. Short, Soo-Young Kang, Souming Wang, Liang Chen, Karin Collett, Ingeborg Bachmann, Kwok‐Kin Wong, Geoffrey I. Shapiro, Karl H. Kalland, Judah Folkman, Randolph S. Watnick, Lars A. Akslen, George N. Naumov

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

    Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma by Yanina Jansen, Elisa A. Rozeman, Robert M. Mason, Simone M. Goldinger, Marnix H. Geukes Foppen, Lise Hoejberg, Henrik Schmidt, Johannes V. van Thienen, John B.A.G. Haanen, Leena Tiainen, Inge Marie Svane, Siru Mäkelä, Teofila Seremet, Ana Arance, Reinhard Dummer, Lars Bastholt, Marta Nyakas, Oddbjørn Straume, Alexander M. Menzies, Georgina V. Long, Victoria Atkinson, Christian U. Blank, Bart Neyns

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: